These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20966900)

  • 1. Cognitive-behavioral treatment of nonalcoholic Fatty liver disease: a propensity score-adjusted observational study.
    Moscatiello S; Di Luzio R; Bugianesi E; Suppini A; Hickman IJ; Di Domizio S; Dalle Grave R; Marchesini G
    Obesity (Silver Spring); 2011 Apr; 19(4):763-70. PubMed ID: 20966900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study.
    Valenti L; Moscatiello S; Vanni E; Fracanzani AL; Bugianesi E; Fargion S; Marchesini G
    QJM; 2011 Feb; 104(2):141-9. PubMed ID: 20851820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
    Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
    Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
    Tilg H; Moschen A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical activity support or weight loss counseling for nonalcoholic fatty liver disease?
    Montesi L; Caselli C; Centis E; Nuccitelli C; Moscatiello S; Suppini A; Marchesini G
    World J Gastroenterol; 2014 Aug; 20(29):10128-36. PubMed ID: 25110440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver disease.
    Trovato GM; Martines GF; Pirri C; Trovato FM; Castro A; Garozzo A; Catalano D
    J Clin Gastroenterol; 2012 Jul; 46(6):e46-54. PubMed ID: 22476041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
    St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
    J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients.
    Forlano R; Ippolito AM; Iacobellis A; Merla A; Valvano MR; Niro G; Annese V; Andriulli A
    Gastrointest Endosc; 2010 May; 71(6):927-33. PubMed ID: 19863955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
    Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
    Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children.
    Grønbæk H; Lange A; Birkebæk NH; Holland-Fischer P; Solvig J; Hørlyck A; Kristensen K; Rittig S; Vilstrup H
    J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):223-8. PubMed ID: 21760546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach.
    Bellentani S; Dalle Grave R; Suppini A; Marchesini G;
    Hepatology; 2008 Feb; 47(2):746-54. PubMed ID: 18098321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.
    Kantartzis K; Thamer C; Peter A; Machann J; Schick F; Schraml C; Königsrainer A; Königsrainer I; Kröber S; Niess A; Fritsche A; Häring HU; Stefan N
    Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight loss as a treatment for nonalcoholic fatty liver disease.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S39-43. PubMed ID: 16540766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice.
    Nobili V; Marcellini M; Devito R; Ciampalini P; Piemonte F; Comparcola D; Sartorelli MR; Angulo P
    Hepatology; 2006 Aug; 44(2):458-65. PubMed ID: 16871574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Adventure therapy' combined with cognitive-behavioral treatment for overweight adolescents.
    Jelalian E; Mehlenbeck R; Lloyd-Richardson EE; Birmaher V; Wing RR
    Int J Obes (Lond); 2006 Jan; 30(1):31-9. PubMed ID: 16158087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
    Marchesini G; Bugianesi E; Forlani G; Cerrelli F; Lenzi M; Manini R; Natale S; Vanni E; Villanova N; Melchionda N; Rizzetto M
    Hepatology; 2003 Apr; 37(4):917-23. PubMed ID: 12668987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.
    Nobili V; Manco M; Devito R; Di Ciommo V; Comparcola D; Sartorelli MR; Piemonte F; Marcellini M; Angulo P
    Hepatology; 2008 Jul; 48(1):119-28. PubMed ID: 18537181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.